Adrian Rabinowicz

Adrian Rabinowicz has extensive work experience in the medical and pharmaceutical field. Adrian is currently serving as the Chief Medical Officer at Neurelis, Inc. since April 2023. Prior to their current position, they held the role of SVP, Clinical Development & Medical Affairs at Neurelis, Inc. from March 2019 to April 2023.

Before joining Neurelis, Inc., Adrian was the Chief Medical Officer at Sancilio & Company from May 2016 to September 2018. Adrian also worked at Acorda Therapeutics as the Senior Vice-President of Clinical Development & Medical Affairs from the unknown start date to April 2016. Adrian gained experience at Bayer Healthcare Pharmaceuticals as the VP of Medical Affairs-Specialty Medicine from January 2007 to February 2010.

Earlier in their career, Adrian held various roles including Executive Director of Specialized Therapeutics at Berlex/Schering AG from January 2005 to December 2006, Director of US Clinical Development & Medical Affairs-Neuroscience at Novartis from January 2002 to December 2004, and Assistant Professor of Neurology at the University of Southern California from January 1992 to December 1997.

In addition to their industry experience, Adrian has also been an Affiliate Professor at the Center for Molecular Biology and Biotechnology at Florida Atlantic University since April 2016.

Adrian Rabinowicz attended The Wharton School in 2009, where they completed an Executive Development Program. From 1978 to 1984, they studied at Universidad del Salvador and obtained a Medical Degree (MD). Adrian also pursued further education at the University of Southern California in the field of Neurology, earning another MD degree. No specific start or end years were provided for their time at the University of Southern California.